Lv4
660 积分 2023-09-17 加入
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
5天前
已完结
Navigating Selective Dose Intensification in EGFR-Variant Non–Small Cell Lung Cancer
5天前
已完结
Advances in the treatment of brain metastases in EGFR-mutant non-small cell lung cancer
6天前
已完结
First-line concomitant EGFR-TKI + chemotherapy versus EGFR-TKI alone for advanced EGFR -mutated NSCLC: a meta-analysis of randomized phase III trials
6天前
已完结
Metastatic sites and survival in lung cancer
22天前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
24天前
已完结
Successful treatment of multiple primary malignancies of EGFR-mutated lung adenocarcinoma and advanced gastric cancer with combination chemoimmunotherapy: a case report
1个月前
已关闭
袖状胃切除加空肠旷置术的研究现状
3个月前
已完结
皖公网安备34019202002308
